Company intelligence / Profile preview

Halosil NXT

New Castle, Delaware, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Halosil International is a healthcare technology company specializing in whole-room surface disinfection solutions designed to eliminate healthcare-associated infections (HAIs). The company's flagship Halo Disinfection System® utilizes a proprietary hydrogen peroxide and ionic silver formula (HaloMist™) delivered via a specialized fogging device (HaloFogger®) to achieve a 6-log kill rate against resistant pathogens like C. difficile and MRSA. Their technology is widely used in hospitals, long-term care facilities, and laboratories to ensure comprehensive environmental hygiene. Halosil's approach combines chemical efficacy with automated delivery to reach surfaces that manual cleaning often misses.

Therapeutic areas: Infectious Diseases
Modalities: DeviceDisinfectant
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Halosil NXT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Halosil NXT.

Explore the full profile